DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 77 filers reported holding DYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,532,489 | -17.6% | 394,251 | +3.5% | 0.00% | 0.0% |
| Q2 2023 | $4,285,440 | +35.5% | 380,928 | +38.8% | 0.00% | 0.0% |
| Q1 2023 | $3,161,929 | -2.9% | 274,473 | -2.3% | 0.00% | 0.0% |
| Q4 2022 | $3,257,195 | -3.8% | 281,035 | +5.4% | 0.00% | 0.0% |
| Q3 2022 | $3,386,000 | +85.2% | 266,581 | +0.2% | 0.00% | – |
| Q2 2022 | $1,828,000 | -26.1% | 266,038 | +3.7% | 0.00% | – |
| Q1 2022 | $2,474,000 | -20.3% | 256,664 | -1.7% | 0.00% | -100.0% |
| Q4 2021 | $3,106,000 | -25.6% | 261,235 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $4,177,000 | -26.5% | 257,212 | -4.8% | 0.00% | 0.0% |
| Q2 2021 | $5,686,000 | +108.7% | 270,231 | +54.0% | 0.00% | 0.0% |
| Q1 2021 | $2,724,000 | -20.1% | 175,445 | +8.1% | 0.00% | 0.0% |
| Q4 2020 | $3,408,000 | – | 162,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $20,335,000 | 17.18% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $34,015,000 | 14.35% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $61,383,000 | 10.26% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,865 | $562,568,000 | 5.87% |
| Logos Global Management LP | 2,900,000 | $19,923,000 | 3.66% |
| Deep Track Capital, LP | 3,500,000 | $24,045,000 | 1.58% |
| HighVista Strategies LLC | 241,867 | $1,662,000 | 1.00% |
| Monashee Investment Management LLC | 319,536 | $2,195,000 | 0.80% |
| RA Capital Management | 2,805,045 | $19,271,000 | 0.51% |
| Vivo Capital, LLC | 577,642 | $3,968,000 | 0.40% |